Login / Signup

Overnight switch from rasagiline to safinamide in Parkinson's disease patients with motor fluctuations: a tolerability and safety study.

Fabrizio StocchiL VaccaP GrassiniC TominoG CaminitiM CasaliV D'AntoniM VolterraniM Torti
Published in: European journal of neurology (2020)
The results of the present study confirm that the overnight switch from rasagiline to safinamide is safe and well tolerated by patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • clinical trial
  • prognostic factors
  • peritoneal dialysis